Viewing Study NCT06302569


Ignite Creation Date: 2025-12-24 @ 10:49 PM
Ignite Modification Date: 2025-12-25 @ 8:19 PM
Study NCT ID: NCT06302569
Status: RECRUITING
Last Update Posted: 2025-09-09
First Post: 2024-02-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
Sponsor: Giuseppe Procopio
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module